Abstract 12993: Administration of Echogenic Immunoliposome-Targeted CD146+ Mesenchymal Stem Cells Reduces Hypercholesterolemia and Atherosclerosis

Introduction and Hypothesis: Mesenchymal stem cells (MSC) have been used to treat atherosclerosis and diabetes in animal studies and clinical trials. We developed a nanotechnology in which MSC can ...